Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
07/2001
07/05/2001US20010006635 Decreasing localized inflammatory responses in a tissue of a patient by administering to said patient heparinase enzyme in an effective amount sufficient to decrease said localized inflammatory response
07/05/2001DE19963178A1 Substituierte Indol-Mannichbasen Substituted indole Mannich bases
07/05/2001DE19962924A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use
07/05/2001CA2699568A1 Azaindoles
07/05/2001CA2396693A1 Cytokine, especially tnf-alpha, inhibitors
07/05/2001CA2396579A1 Tricyclic protein kinase inhibitors
07/05/2001CA2396516A1 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments
07/05/2001CA2396502A1 Substituted pyrrole mannich bases
07/05/2001CA2396039A1 Gfr.alpha.1-ret specific agonists and methods therefor
07/05/2001CA2395996A1 Neuroprotective drug
07/05/2001CA2395950A1 Cells capable of differentiating into heart muscle cells
07/05/2001CA2395663A1 Cyclic amp-specific phosphodiesterase inhibitors
07/05/2001CA2395575A1 Uses of transport proteins for controlling cell cycle
07/05/2001CA2395561A1 Benzophenone glycopyranosides, preparation and therapeutic use
07/05/2001CA2395557A1 Benzophenone alpha-d-glycopyranosides, preparation and therapeutic use
07/05/2001CA2395548A1 Imidazo 1,3,5 triazinones and the use thereof
07/05/2001CA2395544A1 Method of achieving persistent transgene expression
07/05/2001CA2395543A1 Cyclic amp-specific phosphodiesterase inhibitors
07/05/2001CA2395418A1 Isoxazolo pyrimidinones and the use thereof
07/05/2001CA2395410A1 Triazolotriazinones and the use thereof
07/05/2001CA2395284A1 Inhibition of gsk-3.beta.
07/05/2001CA2395275A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof
07/05/2001CA2395249A1 Substituted piperazine derivatives, the preparation thereof and their use as medicaments
07/05/2001CA2395179A1 Nitrile derivatives as cathepsin k inhibitors
07/05/2001CA2395173A1 Pyrrolidines which inhibit camp-specific pde
07/05/2001CA2394944A1 Combinations of a receptor tyrosine kinase inhibitor with an organic compound capable of binding to .alpha.1-acidic glycoprotein
07/05/2001CA2394727A1 Pyrimidine and triazine kinase inhibitors
07/05/2001CA2394174A1 A molecular switch for regulating mammalian gene expression
07/05/2001CA2394098A1 Substituted 1 and 2 naphthol mannich bases
07/05/2001CA2394097A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
07/05/2001CA2393583A1 Compounds active at the glucocorticoid receptor
07/05/2001CA2393529A1 Inhibitors of complement activation, their preparation and use
07/05/2001CA2392866A1 Substituted indole mannich bases
07/04/2001EP1113014A1 Linear or cyclic ureas, a process for their preparation and pharmaceutical compositions containing them
07/04/2001EP1113011A1 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
07/04/2001EP1113007A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
07/04/2001EP1112381A1 Polymorphisms in the human alpha4 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases
07/04/2001EP1112368A1 Use of protein kinase kiaa0551 as pharmaceutical
07/04/2001EP1112365A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
07/04/2001EP1112362A2 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN
07/04/2001EP1112361A2 Promotion or inhibition of angiogenesis and cardiovascularization
07/04/2001EP1112275A1 Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
07/04/2001EP1112271A1 Ergoline amine derivatives with blood pressure lowering effect
07/04/2001EP1112266A1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
07/04/2001EP1112255A1 4,4-biarylpiperidine derivatives with opioid receptor activity
07/04/2001EP1112251A1 Azetidine derivatives, preparation and medicines containing them
07/04/2001EP1112090A2 Method of stimulating prosaposin receptor activity
07/04/2001EP1112089A1 Compositions comprising sympathomimetic amine salts unsuitable for illegal use
07/04/2001EP1112088A1 Method for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
07/04/2001EP1112085A1 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody
07/04/2001EP1112083A2 Use of an angiogenic factor for the treatment of microvascular angiopathies
07/04/2001EP1112070A1 Novel substituted triazole compounds
07/04/2001EP1112005A1 Antioxidant composition comprising acetyl l-carnitine and alpha-lipoic acid
07/04/2001EP0850236B1 Piperazino derivatives as neurokinin antagonists
07/04/2001EP0783308B1 Use of 9-deoxy prostaglandin derivatives to treat glaucoma
07/04/2001CN1302301A Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidine sas inhibitors of cellular proliferation
07/04/2001CN1302296A Novel 2-alkyl substituted imidazole compounds
07/04/2001CN1302208A Smilagenin and anzurogenin-D for curing Alzheimer's disease
07/04/2001CN1302206A Therapeutic uses of quinoline derivatives
07/04/2001CN1302205A Use of benzofuroxan derivatives in treating angina pectoris
07/04/2001CN1302204A Novel fatty analogues for treatment of diabetes
07/04/2001CN1301699A New direct chain or cyclic urea, its preparing method and medicinal composition containing them
07/04/2001CN1301558A Compound ginkgo health product and preparing method
07/04/2001CN1301554A Medicine for curing coronary heart disease
07/04/2001CN1301549A Method for producing chinese medicine for curing cardio-cerebrol vascular disease
07/04/2001CN1301545A Compound depressor
07/04/2001CN1301539A Hemorrhoid medicine
07/04/2001CN1068001C Heterocycle substituted propenoid acid derivatives as NMDA antagonists
07/04/2001CN1068000C Apolioprotein -B synthesis inhibitors
07/04/2001CN1067991C Aminoalkyl substituted benzo-heterocyclic compounds
07/04/2001CN1067987C 取代的吲哚衍生物 Substituted indole derivatives
07/04/2001CN1067986C 1H-indole-3-acetic acid hydrazide phospholipid enzyme A2 inhibitors
07/04/2001CN1067880C Pingyasan for hypertension
07/03/2001US6255512 High energy oxidizing agents in explosive compositions, propellant formulations, gas-generating compositions, andpharmaceutical agents
07/03/2001US6255471 CRFG-1b, a target and marker for chronic renal failure
07/03/2001US6255468 MPROT12 polynucleotides and methods thereof
07/03/2001US6255453 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
07/03/2001US6255330 Heterocyclically substituted phenylglycinolamides
07/03/2001US6255327 Diphenyl-substituted heterocycles, processes for preparing them and their use as pharmaceutical compositions
07/03/2001US6255319 5-aryl-3-(8-azabicyclo[3.2.1]oct-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives as 5-ht4 receptor ligands
07/03/2001US6255306 4-indole derivatives as serotonin agonists and antagonists
07/03/2001US6255298 Using an aromatic amide compound
07/03/2001US6255281 Complexing uteroglobin to fibronectin
07/03/2001CA2132512C Bioadhesive pharmaceutical composition used for the controlled release of active ingredient
07/03/2001CA2107466C Low density microspheres and their use as contrast agents for computed tomography
06/2001
06/30/2001CA2293852A1 Procedure for preparing active plant extracts used to trap free radicals; the extracts and compounds and devices containing them
06/29/2001CA2328781A1 Novel antibacterial and prokinetic macrolides
06/28/2001WO2001046455A2 Survivin promotion of angiogenesis
06/28/2001WO2001046443A2 Proteases
06/28/2001WO2001046415A1 Novel tachykinin-like polypeptides and use thereof
06/28/2001WO2001046397A2 Human kinases
06/28/2001WO2001046394A2 Mammalian protein phosphatases
06/28/2001WO2001046392A2 Homologues of human heparanase and splice variants thereof
06/28/2001WO2001046263A1 Novel compounds
06/28/2001WO2001046258A2 Transporters and ion channels
06/28/2001WO2001046256A2 Vesicle trafficking proteins
06/28/2001WO2001046255A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
06/28/2001WO2001046218A2 Fragments of pf4 and pharmaceutical compositions containing the same
06/28/2001WO2001046206A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
06/28/2001WO2001046205A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)